The Moving Average Convergence Divergence (MACD) for IRON turned positive on October 19, 2026. Looking at past instances where IRON's MACD turned positive, the stock continued to rise in 44 of 48 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on IRON as a result. In 81 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
IRON moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +39.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRON advanced for three days, in 243 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The 10-day RSI Indicator for IRON moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 27 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
IRON broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IRON entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.472) is normal, around the industry mean (2.973). P/E Ratio (-11.385) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. IRON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The RSI Indicator for VYGR moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +15.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where VYGR advanced for three days, in 229 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
VYGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day moving average for VYGR crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for VYGR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.742) is normal, around the industry mean (2.973). P/E Ratio (-1.028) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (5.263) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. VYGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IRON | VYGR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 17 Undervalued | 45 Fair valued | |
PROFIT vs RISK RATING 1..100 | 61 | 100 | |
SMR RATING 1..100 | 97 | 98 | |
PRICE GROWTH RATING 1..100 | 46 | 89 | |
P/E GROWTH RATING 1..100 | 42 | 14 | |
SEASONALITY SCORE 1..100 | 29 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRON's Valuation (17) in the null industry is in the same range as VYGR (45) in the Biotechnology industry. This means that IRON’s stock grew similarly to VYGR’s over the last 12 months.
IRON's Profit vs Risk Rating (61) in the null industry is somewhat better than the same rating for VYGR (100) in the Biotechnology industry. This means that IRON’s stock grew somewhat faster than VYGR’s over the last 12 months.
IRON's SMR Rating (97) in the null industry is in the same range as VYGR (98) in the Biotechnology industry. This means that IRON’s stock grew similarly to VYGR’s over the last 12 months.
IRON's Price Growth Rating (46) in the null industry is somewhat better than the same rating for VYGR (89) in the Biotechnology industry. This means that IRON’s stock grew somewhat faster than VYGR’s over the last 12 months.
VYGR's P/E Growth Rating (14) in the Biotechnology industry is in the same range as IRON (42) in the null industry. This means that VYGR’s stock grew similarly to IRON’s over the last 12 months.
| IRON | VYGR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 68% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 73% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 84% | N/A |
| MACD ODDS (%) | 1 day ago 90% | N/A |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 84% |
| Advances ODDS (%) | 3 days ago 83% | 3 days ago 83% |
| Declines ODDS (%) | 1 day ago 77% | 1 day ago 82% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 72% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRON’s FA Score shows that 1 FA rating(s) are green while VYGR’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRON’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).
IRON (@Biotechnology) experienced а +36.35% price change this week, while VYGR (@Biotechnology) price change was -9.71% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
IRON is expected to report earnings on Nov 05, 2026.
VYGR is expected to report earnings on Nov 09, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, IRON has been loosely correlated with NCEL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then NCEL could also see price increases.
| Ticker / NAME | Correlation To IRON | 1D Price Change % | ||
|---|---|---|---|---|
| IRON | 100% | -1.28% | ||
| NCEL - IRON | 54% Loosely correlated | -12.37% | ||
| AMLX - IRON | 39% Loosely correlated | -1.58% | ||
| REPL - IRON | 38% Loosely correlated | +2.30% | ||
| MLTX - IRON | 38% Loosely correlated | +15.87% | ||
| VYGR - IRON | 37% Loosely correlated | -7.92% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LFAW | 166.82 | 3.76 | +2.31% |
| LifeX 2060 Longevity Income ETF (LFAW) | |||
| MMIT | 23.50 | 0.19 | +0.82% |
| NYLIM MacKay Muni Intermediate ETF (MMIT) | |||
| HERD | 51.32 | 0.37 | +0.73% |
| Pacer Cash Cows Fund of Funds ETF (HERD) | |||
| JUCY | 21.85 | 0.05 | +0.25% |
| Aptus Enhanced Yield ETF (JUCY) | |||
| TSII | 13.38 | -0.23 | -1.65% |
| REX TSLA Growth & Income ETF (TSII) | |||